Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depression

More than eleven million U.S. Veterans are at least 65 years of age, an age group of which almost 20% suffers from clinically significant depressive symptoms. Available pharmacological treatments are suboptimal for patients, including veterans, with late-life depression. Ketamine has emerged as a po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contemp Clin Trials Commun
Hauptverfasser: O'Brien, Brittany, Green, Charles E., Al-Jurdi, Rayan, Chang, Lee, Lijffijt, Marijn, Iqbal, Sidra, Iqbal, Tabish, Swann, Alan C., Mathew, Sanjay J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6727003/
https://ncbi.nlm.nih.gov/pubmed/31508531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100432
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge